Treatment adherence patterns for patients with atherosclerotic cardiovascular disease: Patient and provider perspectives
{{output}}
Background: Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of mortality, affecting more than 500 million individuals globally. National guidelines recommend lipid-lowering therapies (LLTs) as first line agents ... ...
